Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,988
Closed -$340K 274
2022
Q1
$340K Sell
1,988
-1,421
-42% -$268K 0.13% 237
2021
Q4
$714K Sell
3,409
-1,054
-24% -$218K 0.23% 194
2021
Q3
$860K Sell
4,463
-18
-0.4% -$4.42K 0.29% 168
2021
Q2
$1.27M Buy
4,481
+844
+23% +$229K 0.37% 154
2021
Q1
$770K Buy
3,637
+1,767
+94% +$423K 0.22% 204
2020
Q4
$367K Buy
+1,870
New +$330K 0.11% 227

Other funds holding MED

Fort LP's MED Position: Q2 2022 in Review

Fort LP sold out of Medifast (MED) in Q2 2022, closing a stake of 1,988 shares — an estimated $340K sold.

Fort LP first reported a position in MED in Q4 2020 and held it in 6 quarters. The position peaked at $1.27M in Q2 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

  • Fort LP reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
  • Fort LP sold 1,988 Medifast shares in Q2 2022, an estimated $340K.
  • Fort LP first reported a position in Medifast in Q4 2020 and held it in 6 quarters.
  • Fort LP's Medifast position peaked at $1.27M in Q2 2021.
  • 284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Fort LP's 13F filing for Q2 2022, filed 12 Aug 2022.